Desk› Healthcare› Morepen Laboratories Ltd

Morepen Laboratories Ltd

BSE 500288 MOREPENLAB INE083A01026

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

18 filings · 9 material · busiest 2026-08-04

What it files

Change in Management3 General3 Press Release2 Acquisition1 Newspaper Publication1 Results1 Board Outcome1 Investor Presentation1

Filings

18 in the window

6 August 2026

Acquisition

Acquisition

Allotment of equity shares by Morepen RX Limited, wholly owned subsidiary of the company

Company Update / Acquisition View filing →
5 August 2026

Newspaper Publication

Newspaper Publication

Newspaper Publication Financial Results for the quarter ended June 30, 2026

Company Update / Newspaper Publication View filing →
4 August 2026

Results

Q1 FY 27 Financial Results

Please find attached the Q1 FY 27 Financial Results

Result / Financial Results View filing →
4 August 2026

Board Outcome

Board Meeting Outcome for For Q1 FY 27 Financial Results

Please find attached the Q1 FY 27 Financial Results

Board Meeting / Outcome of Board Meeting View filing →
4 August 2026

Investor Presentation

Investor Presentation

Please find attached the Q1 FY 27 Investor Presentation

Company Update / Investor Presentation View filing →
4 August 2026

Press Release

Press Release / Media Release

Please find attached the Press Release

Company Update / Press Release / Media Release View filing →
4 August 2026

Record Date

Intimation Of Record Date For Payment Of Final Dividend I.E. September 19, 2026

Please find attached the file

Corp. Action / Record Date View filing →
4 August 2026

Change in Management

Change in Management

Re-appointment of Mr. Sushil Suri as Chairman & Managing Director w.e.f. October 20, 2026

Company Update / Change in Management View filing →
4 August 2026

General

Intimation Of Annual General Meeting

41st Annual General Meeting scheduled to be held on September 26, 2026

Company Update / General View filing →
4 August 2026

Monitoring Agency

Monitoring Agency Report

Please find attached the monitoring agency report for the quarter ended June 30, 2026

Company Update / Monitoring Agency Report View filing →
28 July 2026

Board Meeting

Board Meeting Intimation for Q-1 FY27 Results

Morepen Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 ,inter alia, to consider and approve financial results for ....

Board Meeting / Board Meeting View filing →
23 July 2026

General

Intimation Of Name Change Of Wholly Owned Subsidiary Company

The name of wholly owned subsidiary company has been changed from Morepen Labs - FZCO to Morepen Labs FZE

Company Update / General View filing →
6 July 2026

Change in Management

Change in Management

Change in Senior Management Personnel on account of Resignation

Company Update / Change in Management View filing →
1 July 2026

Press Release

Press Release / Media Release

Please find enclosed the Press Release

Company Update / Press Release / Media Release View filing →
30 June 2026

Change in Management

Change in Management

Elevation and change in designation of Mr. Sanjay Suri

Company Update / Change in Management View filing →
26 June 2026

Trading Window

Closure of Trading Window

closure of trading window for DP and their immediate relatives for the quarter ended 30 June 2026

Insider Trading / SAST / Closure of Trading Window View filing →
10 June 2026

Clarification

Clarification sought from Morepen Laboratories Ltd

The Exchange has sought clarification from Morepen Laboratories Ltd on June 10, 2026, with reference to Movement in Volume. The reply is awaited.

Company Update / Clarification
10 June 2026

General

Reply To Clarification On Price Movement

Please find enclosed the reply

Company Update / General View filing →